Oncology Institute, Inc. (TOI) Stock Price, Financials & Summary

Price chart

Jul 31Aug 5Aug 10Aug 13Aug 18Aug 21Aug 26Aug 31

Key dataAug 31, 2026

Open$6.20

From 52W high−22.97%

Volume1.35M

Market cap$512.91M

P/E (TTM)—

P/S (TTM)0.9x

Div yield—

Key dataAug 31, 2026

Open

$6.20

From 52W high

−22.97%

Volume

1.35M

Market cap

$512.91M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−26.8x

P/E (TTM)

—

RSI (14)

48.5

MomentumView details →

1D Return

−19.72%

YTD Return

+66.01%

SummaryUpdated Jun 1, 2026

The Oncology Institute, Inc. (NASDAQ:TOI) is a community-based oncology company founded in 2007 and headquartered in Cerritos, California. The company went public in June 2020 and has grown to become one of the largest value-based oncology providers in the United States. Operating 67 clinic locations across multiple states, TOI specializes in providing comprehensive cancer care services to adult and senior cancer patients through a network of over 100 specialty-trained physicians and healthcare providers.

Ask drillr about Oncology Institute, Inc. →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−26.8x

EV/Sales

0.8x

P/S (TTM)

0.9x

P/B (TTM)

−20.6x

ProfitabilityView details →

Gross Margin

10.79%

Net Margin

−6.18%

EBITDA Margin

−3.16%

ROE (TTM)

145.67%

ROA (TTM)

−20.36%

Asset Turnover

3.39x

GrowthView details →

Revenue YoY

+38.38%

EPS YoY

+58.82%

FCF YoY

+74.87%

Revenue CAGR 3Y

+25.81%

EPS CAGR 3Y

+23.94%

EBITDA YoY

+61.60%

MomentumView details →

1D Return

−19.72%

YTD Return

+66.01%

1Y Return

+81.85%

RSI (14)

48.5

vs 50D SMA

+4.02%

vs 200D SMA

+45.83%

Capital & dividendView details →

Debt/Equity

−0.99x

Current Ratio

1.36x

Quick Ratio

1.15x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.02

EPS Surprise

71.43%

Beats (12Q)

3/12

Next Q EPS Est

—

Avg Surprise (4Q)

36.63%

Rev Surprise

3.76%

Financials snapshotView financials →

Revenue (TTM)

587.24M

Net Income (TTM)

−36.29M

Op. CF (TTM)

328000.00

Latest newsMore news →

Oncology Institute announced it has rebranded as Starling Oncology.44d ago

Oncology Institute, Inc. issued warrants exercisable for 10,025,535 shares of its common stock to Deerfield Partners, L.P. and affiliates, with an initial exercise price of $8.567 per share and expiration on August 9, 2027.76d ago

Similar companies

Beijing Health (Holdings) Limited02389.HK Wuhan Dazhong Dental Medical Co., Ltd.02651.HK Concord Healthcare Grp Co Ltd02453.HK Hospital Corporation of China Limited03869.HK Kato (Hong Kong) Holdings Limited02189.HK SoftMedx Healthcare Limited02951.HK Find similar companies →

Latest newsMore news →

Oncology Institute announced it has rebranded as Starling Oncology.44d ago Oncology Institute, Inc. issued warrants exercisable for 10,025,535 shares of its common stock to Deerfield Partners, L.P. and affiliates, with an initial exercise price of $8.567 per share and expiration on August 9, 2027.76d ago